Sensyne Health PLC
LSE:SENS
Sensyne Health PLC
Cost of Revenue
Sensyne Health PLC
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sensyne Health PLC
LSE:SENS
|
Cost of Revenue
-£3.2m
|
CAGR 3-Years
-156%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Renalytix PLC
LSE:RENX
|
Cost of Revenue
-$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Craneware PLC
LSE:CRW
|
Cost of Revenue
-$26.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-27%
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Cost of Revenue
-£4.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Instem PLC
LSE:INS
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EMIS Group PLC
LSE:EMIS
|
Cost of Revenue
-£10.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
See Also
What is Sensyne Health PLC's Cost of Revenue?
Cost of Revenue
-3.2m
GBP
Based on the financial report for Apr 30, 2021, Sensyne Health PLC's Cost of Revenue amounts to -3.2m GBP.
What is Sensyne Health PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-156%
Over the last year, the Cost of Revenue growth was -258%. The average annual Cost of Revenue growth rates for Sensyne Health PLC have been -156% over the past three years .